Call for proposals to support access to medical devices for cross border health threats (HERA) (CP-g-23-13)
Programme Category
Programme Name
Programme Description
The Programme aims to improve and promote health in the Union to reduce the burden of communicable and non-communicable diseases by:
- protecting people from serious cross-border health threats
- improving the availability, accessibility and affordability of medicines, medical devices and other crisis-related products in the EU
- strengthening national health systems
Identifier Code
Call
Summary
This action supports the policy priority to increase patients’ access to medical countermeasures and it implements the EU4Health Programme’s general objective of improving the availability, accessibility and affordability of medicinal products and medical devices, and crisis-relevant products in the Union, and supporting innovation regarding such products.
This action aims to support consortia that provide a platform of experienced regulatory, business planning, and device development services to help foster and guide the advancement of devices that can be used in case of serious cross border health threats.
Detailed Call Description
This action is part of the Crisis Preparedness strand related to improving the availability, accessibility and affordability of medicinal products and medical devices, and crisis-relevant products in the Union, and supporting innovation regarding such products.
This action does not cover orphan medical devices (medical devices for rare diseases), as these are addressed by a specific action within this work programme.
The consortia should facilitate the development, production, and distribution of these devices that can be used in case of serious cross-border health threats by providing services and advice on intellectual property, prototyping, engineering, laboratory and animal testing, grant-writing, and clinical investigation design.
A consortium should bring together different associations, organisations and/or institutions that can support medical device advancement through all stages of development: concept formation, prototyping, preclinical, clinical, manufacturing, marketing, and commercialisation.
The activities will target medical devices and in vitro diagnostic medical devices that can be relevant for preparedness and response to cross-border health threats.
Call Total Budget
Financing percentage by EU or other bodies / Level of Subsidy or Loan
The costs will be reimbursed at the funding rate fixed in the Grant Agreement (60%). Your organisation can apply for a higher project funding rate (80%) if your project is of “exceptional utility”. Actions shall be considered to have exceptional utility where at least 30% of the budget of the proposed action is allocated to Member States whose GNI per inhabitant is less than 90% of the Union average; or the project concerns actions with bodies from at least 14 Member States and where at least 4 are from Member States whose GNI per inhabitant is less than 90% of the EU average.
Thematic Categories
- Health
- Public Administration
- Small-Medium Enterprises and Competitiveness
Eligibility for Participation
- Educational Institutions
- International Organisations
- Large Enterprises
- NGOs
- Non Profit Organisations
- Other Beneficiaries
- Private Bodies
- Small and Medium Enterprises (SMEs)
- State-owned Enterprises
Eligibility For Participation Notes
Applications will only be considered eligible if their content corresponds wholly (or at least in part) to the topic description for which it is submitted.
In order to be eligible, the applicants (beneficiaries and affiliated entities) must:
- be legal entities (public or private bodies)
- be established in one of the eligible countries, i.e.:
- EU Member States (including overseas countries and territories (OCTs)
- eligible non-EU countries:
- listed EEA countries and countries associated to the EU4Health Programme or countries which are in ongoing negotiations for an association agreement and where the agreement enters into force before grant signature (list of participating countries)
Type of applicants targeted: Scientific societies, academia, health authorities/institutions and NGOs, possibly also including SMEs active and with expertise in the area of the action.
Specific eligibility and selection criteria applicable to the consortium composition: Proposals must be submitted by a consortium of at least 3 applicants (beneficiaries; not affiliated entities), which complies with the following conditions: minimum 3 entities from 3 different eligible countries. etc.
Call Opening Date
Call Closing Date
National Contact Point(s)
Ministry of Health, Department of European Affairs
Ms MAKRIGIORGI Elena
emakrigiorgi@moh.gov.cy
EU Contact Point
Stefan DE KEERSMAECKER
+32 2 298 46 80
stefan.de-keersmaecker@ec.europa.eu
Darragh CASSIDY
+32 2 298 39 78